Hap Trading, LLC Cassava Sciences Inc Call Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$9.57 - $35.08 $622,050 - $2.28 Million	65,000 New	65,000 $1.39 Billion
Q1 2024 May 13, 2024	SELL	$18.44 - $26.41 $2.97 Million - $4.25 Million	-161,000 Reduced 65.45%	85,000 $58.7 Million
Q4 2023 Feb 14, 2024	BUY	$12.64 - $30.11 $3.11 Million - $7.41 Million	246,000 New	246,000 $249 Million
Q2 2023 Aug 11, 2023	SELL	$21.59 - $27.88 $4.35 Million - $5.62 Million	-201,500 Reduced 92.6%	16,100 $394,000
Q1 2023 May 12, 2023	SELL	$23.46 - $36.44 $1.92 Million - $2.98 Million	-81,800 Reduced 27.32%	217,600 $55,000
Q4 2022 Feb 14, 2023	BUY	$27.82 - $44.16 $7.32 Million - $11.6 Million	263,000 Added 722.53%	299,400 $820,000
Q3 2022 Nov 14, 2022	SELL	$16.33 - $51.06 $120,841 - $377,844	-7,400 Reduced 16.89%	36,400 $278,000
Q2 2022 Aug 12, 2022	BUY	$17.22 - $38.47 $125,705 - $280,831	7,300 Added 20.0%	43,800 $134,000
Q1 2022 May 12, 2022	BUY	$32.6 - $53.05 $645,480 - $1.05 Million	19,800 Added 118.56%	36,500 $273,000
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $125,018 - $309,094	3,400 Added 25.56%	16,700 $217,000
Q3 2021 Nov 10, 2021	SELL	$41.79 - $135.3 $405,363 - $1.31 Million	-9,700 Reduced 42.17%	13,300 $149,000
Q2 2021 Aug 11, 2021	SELL	$32.15 - $89.72 $2.72 Million - $7.6 Million	-84,700 Reduced 78.64%	23,000 $524,000
Q1 2021 May 14, 2021	BUY	$7.09 - $87.95 $630,301 - $7.82 Million	88,900 Added 472.87%	107,700 $717,000
Q4 2020 Feb 16, 2021	BUY	$6.79 - $12.25 $127,652 - $230,300	18,800 New	18,800 $49,000
Q3 2020 Nov 13, 2020	SELL	$2.86 - $11.51 $441,584 - $1.78 Million	-154,400 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$2.04 - $9.64 $314,976 - $1.49 Million	154,400 New	154,400 $11,000

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

Black Rock Inc. New York, NY

3.22M
Shares

$9.18 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.52M
Shares

$7.19 Million
0.0% of portfolio
State Street Corp Boston, MA

1.16M
Shares

$3.31 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.01M
Shares

$2.87 Million
0.0% of portfolio
Gallacher Capital Management LLC Lone Tree, CO

580K
Shares

$1.65 Million
7.83% of portfolio

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $114M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account